SRI-37330 HCl manufacturers
|
| | SRI-37330 HCl Basic information |
| Product Name: | SRI-37330 HCl | | Synonyms: | SRI 37330 HCl;SRI 37330 hydrochloride;SRI37330 HCl;SRI-37330 HCl;SRI37330 hydrochloride;SRI-37330 hydrochloride;N-((1-(6-(trifluoromethyl)quinazolin-4-yl)piperidin-3-yl)methyl)methanesulfonamide hydrochloride | | CAS: | 2322245-49-6 | | MF: | C16H20ClF3N4O2S | | MW: | 424.87 | | EINECS: | | | Product Categories: | | | Mol File: | 2322245-49-6.mol |  |
| | SRI-37330 HCl Chemical Properties |
| storage temp. | 4°C, away from moisture | | solubility | DMSO:62.5(Max Conc. mg/mL);147.1(Max Conc. mM) | | form | Solid | | color | White to light yellow |
| | SRI-37330 HCl Usage And Synthesis |
| Description | SRI-37330 hydrochloride is a novel inhibitor of TXNIP expression, decreasing glucagon secretion and action and blocking hepatic glucose output, reversing obesity- and STZ-induced diabetes and hepatic steatosis. | | target | SRI-37330 hydrochloride is an orally bioavailable thioredoxin-interacting protein (TXNIP) inhibitor. |
| | SRI-37330 HCl Preparation Products And Raw materials |
|